Should the interval between doses of antenatal corticosteroids be shortened in certain cases? Factors predicting preterm delivery < 48 h from presentation.
Antenatal corticosteroids
Prematurity
Preterm birth
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
20
08
2020
accepted:
12
03
2021
pubmed:
31
3
2021
medline:
30
10
2021
entrez:
30
3
2021
Statut:
ppublish
Résumé
Treatment with antenatal corticosteroids (ACS) to women at risk for preterm birth (PTB) is associated with a reduction in adverse neonatal outcomes. Obstetricians occasionally shorten the interval between the doses of steroids if delivery is predicted to occur before ACS are fully administered. In this study, we aimed to investigate predicting factors to identify patients that will deliver prematurely, less than 48 h from presentation. The computerized medical files of all PTBs (< 34 weeks) were reviewed. Maternal demographics, pregnancy and delivery characteristics were compared between PTB that occurred < 48 h vs. > 48 h from triage presentation. In total, 494 PTB cases were included: 302 women in the study group (PTB < 48 h) and 192 women in the control group (PTB > 48 h). No significant differences were found in demographic characteristics between the groups. At presentation, the study group had higher rates of uterine contractions (p < 0.001) and cervical length < 25 mm (p < 0.001) as well as a higher rate of non-reassuring fetal (NRFHR) monitor (p < 0.001). In contrast, the control group presented with higher rates of preeclampsia (p = 0.003) and preterm premature rupture of membranes (p = 0.038). In multivariable analysis, all of the above factors remained significant after controlling for background confounders. Various factors at presentation can predict delivery < 48 h. These factors can be used to predict patients to whom the ACS interval should be shortened. Future prospective studies should investigate the effect of this shortening on neonatal outcomes.
Identifiants
pubmed: 33782713
doi: 10.1007/s00404-021-06032-8
pii: 10.1007/s00404-021-06032-8
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
913-918Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
McCormick MC (1985) The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. https://doi.org/10.1056/NEJM198501103120204
doi: 10.1056/NEJM198501103120204
pubmed: 3880598
Manuck TA, Rice MM, Bailit JL et al (2016) Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. Am J Obstet Gynecol. https://doi.org/10.1016/j.ajog.2016.01.004
doi: 10.1016/j.ajog.2016.01.004
pubmed: 27418444
pmcid: 5086280
Murphy SL, Mathews TJ, Martin JA, Minkovitz CS, Strobino DM (2017) Annual summary of vital statistics: 2013–2014. Pediatrics. https://doi.org/10.1542/peds.2016-3239
doi: 10.1542/peds.2016-3239
pubmed: 29271733
CDC (2016) FastStats—births and natality. Centers Dis Control
Roberts D, Brown J, Medley N, Dalziel SR (2017) Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004454.pub3
doi: 10.1002/14651858.CD004454.pub3
pubmed: 28881002
pmcid: 6486201
Simhan HN (2016) Practice bulletin no. 171: management of preterm labor. Obstet Gynecol. https://doi.org/10.1097/AOG.0000000000001711
doi: 10.1097/AOG.0000000000001711
pubmed: 26959201
pmcid: 4805458
Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA (2013) Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006764.pub3
doi: 10.1002/14651858.CD006764.pub3
pubmed: 23990333
Khandelwal M, Chang E, Hansen C, Hunter K, Milcarek B (2012) Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial. Am J Obstetr Gynecol. https://doi.org/10.1016/j.ajog.2012.01.025
doi: 10.1016/j.ajog.2012.01.025
Haas DM, McCullough W, McNamara MF, Cara O (2006) The first 48 hours: comparing 12-hour and 24-hour betamethasone dosing when preterm deliveries occur rapidly. J Matern Neonatal Med. https://doi.org/10.1080/14767050600715873
doi: 10.1080/14767050600715873
Kashanian M, Eshraghi N, Sheikhansari N, Bordbar A, Khatami E (2018) Comparison between two doses of betamethasone administration with 12 hours vs. 24 hours intervals on prevention of respiratory distress syndrome: a randomised trial. J Obstet Gynaecol (Lahore) 38(6):770–776. https://doi.org/10.1080/01443615.2017.1413080
doi: 10.1080/01443615.2017.1413080
Skoll A, Boutin A, Bujold E et al (2018) No. 364-antenatal corticosteroid therapy for improving neonatal outcomes. J Obstet Gynaecol Can 40(9):1219–1239. https://doi.org/10.1016/j.jogc.2018.04.018
doi: 10.1016/j.jogc.2018.04.018
pubmed: 30268316
Grimbizis GF, Gordts S, Di Spiezio SA et al (2013) The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies. Hum Reprod. https://doi.org/10.1093/humrep/det098
doi: 10.1093/humrep/det098
pubmed: 23771171
pmcid: 3712660
ACOG practice bulletin no. 202: gestational hypertension and preeclampsia (2019). Obstet Gynecol. https://doi.org/10.1097/AOG.0000000000003018
Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon E (2001) Birthweight standards in the live-born population in Israel. Isr Med Assoc 7:311–314
Melamed N, Shah J, Soraisham A et al (2015) Association between antenatal corticosteroid administration-to-birth interval and outcomes of preterm neonates. Obstet Gynecol. https://doi.org/10.1097/AOG.0000000000000840
doi: 10.1097/AOG.0000000000000840
pubmed: 26551181
Wilms FF, Vis JY, Pattinaja DAPM et al (2011) Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity. Am J Obstet Gynecol. https://doi.org/10.1016/j.ajog.2011.03.035
doi: 10.1016/j.ajog.2011.03.035
pubmed: 21620358
Peaceman AM, Bajaj K, Kumar P, Grobman WA (2005) The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstetr Gynecol. https://doi.org/10.1016/j.ajog.2005.06.050
doi: 10.1016/j.ajog.2005.06.050
Jobe AH, Soll RF (2004) Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol. https://doi.org/10.1016/j.ajog.2004.01.044
doi: 10.1016/j.ajog.2004.01.044
pubmed: 15547543
Romejko-Wolniewicz E, Teliga-Czajkowska J, Czajkowski K (2014) Antenatal steroids: can we optimize the dose? Curr Opin Obstet Gynecol. https://doi.org/10.1097/GCO.0000000000000047
doi: 10.1097/GCO.0000000000000047
pubmed: 24463225
pmcid: 3966924
Elimian A, Figueroa R, Spitzer AR, Ogburn PL, Wiencek V, Quirk JG (2003) Antenatal corticosteroids: are incomplete courses beneficial? Obstet Gynecol. https://doi.org/10.1016/S0029-7844(03)00485-X
doi: 10.1016/S0029-7844(03)00485-X
pubmed: 12907112
Romero R, Dey SK, Fisher SJ (2014) Preterm labor: one syndrome, many causes. Science. https://doi.org/10.1126/science.1251816
doi: 10.1126/science.1251816
pubmed: 25342811
pmcid: 4336192